S0017 HCPCS Level II code: Injection, aminocaproic acid, 5 grams
CMS terminated S0017: its last date of service was Mar 31, 2025. It stays here for looking up older claims; newer services need a current code.
Official description
S0017Injection, aminocaproic acid, 5 grams
Short description: Injection, aminocaproic acid
HCPCS · United States
Notes for S0017
As CMS prints them, with any note S0017 takes from the headings above it.
Note
- CMS processing note 0088: "S" CODES ARE UNIQUE TEMPORARY CODES ESTABLISHED BY BCBSA AND HIAA FOR PRIVATE PAYOR USE. THEY ARE NOT VALID NOR PAYABLE BY MEDICARE.
Medicare details
The indicators CMS publishes with S0017 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Not payable by Medicare
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Undefined codes
- Added
- Jan 1, 2000
- Terminated after
- Mar 31, 2025
Where S0017 sits
- 1S codesTemporary national codes (non-Medicare)
- 2Terminated S0017Injection, aminocaproic acid, 5 grams
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code S0017 still valid?
No. CMS terminated S0017; its last date of service was Mar 31, 2025. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover S0017?
CMS lists S0017’s Medicare coverage as “Not payable by Medicare” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside S0017
All S codesS0012Butorphanol tartrate, nasal spray, 25 mgS0013Esketamine, nasal spray, 1 mgS0014Tacrine hydrochloride, 10 mgS0020Injection, bupivicaine hydrochloride, 30 mlS0021Injection, cefoperazone sodium, 1 gramS0023Injection, cimetidine hydrochloride, 300 mgS0028Injection, famotidine, 20 mgS0030Injection, metronidazole, 500 mgS0032Injection, nafcillin sodium, 2 grams